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I.  Introduction 
 
In Madison County, Illinois, lawsuits are commonplace. In 2019, 4,062 
asbestos-related lawsuits were filed in the United States.1 Of those, 1,150, or 
28.3%, were filed in Madison County, easily making it the top jurisdiction 
for asbestos litigation.2 In contrast, St. Clair County, Illinois, immediately 
south of Madison County, ranked in at a not-so-close second place for 
asbestos litigation, with 9% of all asbestos-related lawsuits nationwide filed 
there in 2019.3 Further, of the plaintiffs who filed asbestos lawsuits in 
Illinois, only 8% resided in the state.4 These statistics, coupled with the fact 
that the average asbestos lawsuit names a whopping sixty-five defendants,5 
are enough to raise the eyebrows of anyone with an elementary 
understanding of personal jurisdiction. 
 
This excessive use of the tort system is not new to Madison County and is 
not limited to the asbestos docket. Over the years the county has garnered 
a reputation as America’s preeminent “judicial hellhole,” a “jackpot 
jurisdiction,” a “local slot machine,” “lawyer heaven,” and an “asbestos 
mecca.”6 Madison County’s tort system abuse problem is so well-known 
that George W. Bush traveled to the county to give a speech on tort reform 
in early 2005.7 Abuse of class certification in class action lawsuits, uniquely 
successful welding rod litigation, and medical malpractice claims that 
literally drove physicians out of the county are just a few additional 
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1 Asbestos Litigation: 2019 Year in Review, KCIC 3 (2020), 
https://www.kcic.com/media/2059/kcic-2019-asbestos-report.pdf. 
2 Id. at 5–6. 
3 Id. 
4 Id. at 12. 
5 Id. at 11. 
6 Victor E. Schwartz et al., Asbestos Litigation in Madison County, Illinois: The Challenge 
Ahead, 16 WASH. U. J.L. & POL'Y 235, 235–36, 243 (2004). 
7 President Bush Visits Collinsville to Discuss Tort Reform, ST. LOUIS BUSINESS JOURNAL (Jan. 
5, 2005), https://www.bizjournals.com/stlouis/stories/2005/01/03/daily37.html. 
 




examples of tort system abuse in the county.8 Madison County was also the 
origin of the famous Philip Morris cigarette case, in which the trial judge 
awarded the plaintiffs’ attorneys a hefty $1.78 billion in fees.9 To say the 
least, Madison County is an attractive option to forum shoppers. 
 
II.  Bristol-Myers Squibb 
 
Over the past decade, the Supreme Court has decided several cases related 
to personal jurisdiction,10 and these cases have done much to discourage 
forum shopping.11 The case most relevant to defendants facing lawsuits 
from nonresident plaintiffs in the Madison County courthouse is Bristol-
Myers Squibb Co. v. Superior Court of California, San Francisco County,12 
wherein the Court dismissed hundreds of nonresident plaintiffs from a 
mass tort lawsuit.13 The Court restated the requirement that, in order for a 
court to exercise jurisdiction, the plaintiff’s claims must “arise out of” or 
“relate to” the defendant’s contacts with the forum state,14 and the case has 
largely been regarded as narrowing that requirement.15 
 
III.  Rios v. Bayer 
 
In 2016 and 2017, two mass tort actions were filed in the circuit court of 
Madison County against pharmaceutical giant Bayer for injuries related to 
Bayer’s Essure device.16 The two suits involved 180 plaintiffs from at least 
twenty-five different states.17 Citing recently-decided Bristol-Myers Squibb, 
 
8 Schwartz, supra note 6, at 239–244. 
9 Vanessa O’Connell, Illinois Judge Orders Philip Morris To Pay $10.1 Billion in Damages, 
WALL ST. J. (Mar. 24, 2003), https://www.wsj.com/articles/SB104829437457872000. 
10 See e.g., Goodyear Dunlop Tires Operations, S.A. v. Brown, 564 U.S. 915 (2011); Daimler 
AG v. Bauman, 571 U.S. 117 (2014); Walden v. Fiore, 571 U.S. 277 (2014). 
11 See generally Howard M. Erichson et al., Case-Linked Jurisdiction and Busybody States, 105 
MINN. L. REV. HEADNOTES (forthcoming 2020). 
12 137 S. Ct. 1773. 
13 Id. at 1777. 
14 Id. at 1780. 
15 See, e.g., Megan Crowe, Can You Relate? Bristol-Myers Narrowed the Relatedness 
Requirement but Changed Little in the Specific Jurisdiction Analysis, 63 ST. LOUIS U. L.J. 505, 
514 (2019) (“The Court’s holding [in Bristol-Myers Squibb] demonstrated an attempt to 
narrow the scope of the relatedness requirement.”). 
16 Rios v. Bayer Corp., Nos. 125020 & 125021, 2020 WL 2963318, at *1 (Ill. Jun. 4, 2020). 
17 Id.  
 




Bayer filed motions to dismiss the nonresident plaintiffs for lack of personal 
jurisdiction.18 The circuit court of Madison County denied the motions to 
dismiss, and Bayer sought an interlocutory appeal.19 After the appellate 
court affirmed the circuit court of Madison County, the cases were 
consolidated and went up to the Illinois Supreme Court.20 
 
Plaintiffs argued that the circuit court had jurisdiction over Bayer because 
it conducted clinical trials for Essure, created a training program for 
physicians related to Essure, and developed a marketing campaign for 
Essure, all in Illinois.21 At the outset of its analysis, the court recognized the 
distinction in personal jurisdiction between general and specific jurisdiction 
and found that general jurisdiction was not at issue.22 Citing Bristol-Myers 
Squibb, the court further recognized that specific jurisdiction requires the 
defendant to purposefully avail itself of contacts in the forum state and that 
the plaintiff’s claims must “arise out of” or “relate to” the defendant’s 
contacts.23 
 
Bayer admitted to having purposefully directed activities at Illinois.24 It did 
not dispute that it had conducted clinical trials, organized a physician 
training program, and created a marketing campaign, all related to its 
Essure device, in Illinois.25 However, Bayer argued, and the court ultimately 
held, that the plaintiffs’ claims did not “arise out of” or “relate to” Bayer’s 
activities in Illinois.26 Plaintiffs, for example, alleged defects in Bayer’s 
manufacturing of Essure, but Essure was manufactured in California, 
Mexico, and Costa Rica — not Illinois.27 Similarly, Plaintiffs alleged Bayer 
“willfully disseminated false and misleading information” about Essure, 
but the nonresident plaintiffs did not allege that they received false 
information about Essure in Illinois.28  
 
18 Id. 
19 Id. at *2. 
20 Id. at *3. 
21 Rios, 2020 WL 2963318, at *4. 
22 Id. 
23 Id. 
24 Id. at *5. 
25 Id. 
26 Rios, 2020 WL 2963318, at *5. 
27 Id. 
28 Id.  
 





“In short,” the court held, “the nonresident plaintiffs have identified no 
jurisdictionally relevant links between their claims and Illinois.”29 The court 
went on to acknowledge that, following Bristol-Myers Squibb, the United 
States District Court for the Eastern District of Missouri had dismissed 
hundreds of nonresident plaintiffs from mass tort lawsuits related to Essure 
across the river in St. Louis on the same grounds.30 Finally, because the 
nonresident plaintiffs had not articulated a reason why Illinois could be a 
convenient location to litigate their claims when they were not implanted 
with or sold Essure in the state, and because Illinois “has no particular 
interest in resolving claims that did not arise out of or relate to activities 
that occurred” in the state, the court concluded that allowing the 
nonresidents plaintiffs’ claims to proceed in Illinois would be 
unreasonable.31 
 
IV.  Conclusion 
 
The Illinois Supreme Court’s recognition of Bristol-Myers Squibb in Rios is a 
victory, not only for defendants being sued in Madison County by plaintiffs 
who do not reside in the state, but also for Illinois residents, who are forced 
to endure the negative economic effects of tort system abuse.32 Although at 
least one expert has speculated that not much is likely to change in Madison 
County,33 Rios could potentially be used to dismiss lawsuits brought against 
asbestos manufacturers and other defendants by nonresident plaintiffs, the 
majority of which could simply bring their lawsuits in the jurisdictions 
where they were sold the allegedly defective products. At the very least, 
 
29 Id. at *6. 
30 Id. 
31 Rios, 2020 WL 2963318, at *7. 
32 See generally Economic Benefits of Tort Reform: An Assessment of Excessive Tort Costs in 
Illinois and Potential Economic Benefits of Reform, THE PERRYMAN GROUP (Nov. 2019), 
https://d3n8a8pro7vhmx.cloudfront.net/cala/pages/67/attachments/original/1582657304/C
ALA_Tort_Reform_Impact_IL_Report.pdf?1582657304. 
33Ann Maher, Bayer Ruling an Important Check on Greed and Fairness of Courts, Asbestos 









Rios is one arrow in the quiver of defendants with deep enough pockets to 
litigate personal jurisdiction. 
 
 
Edited by Ben Davisson 
 
 
 
